Advanced company searchLink opens in new window

C. S. T. PHARMA LIMITED

Company number 04212740

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
08 Apr 2024 MR01 Registration of charge 042127400012, created on 27 March 2024
16 Jan 2024 AA Full accounts made up to 30 April 2023
09 May 2023 CS01 Confirmation statement made on 9 May 2023 with no updates
30 Jan 2023 TM01 Termination of appointment of Michelle Grenan as a director on 30 January 2023
05 Jan 2023 AA Full accounts made up to 30 April 2022
09 May 2022 CS01 Confirmation statement made on 9 May 2022 with no updates
03 Dec 2021 MR04 Satisfaction of charge 4 in full
03 Dec 2021 MR04 Satisfaction of charge 5 in full
03 Dec 2021 MR04 Satisfaction of charge 042127400006 in full
20 Oct 2021 AA Full accounts made up to 30 April 2021
06 Aug 2021 MR01 Registration of charge 042127400007, created on 30 July 2021
06 Aug 2021 MR01 Registration of charge 042127400008, created on 30 July 2021
06 Aug 2021 MR01 Registration of charge 042127400009, created on 30 July 2021
06 Aug 2021 MR01 Registration of charge 042127400010, created on 30 July 2021
06 Aug 2021 MR01 Registration of charge 042127400011, created on 30 July 2021
10 May 2021 CS01 Confirmation statement made on 9 May 2021 with no updates
10 Feb 2021 AA Full accounts made up to 30 April 2020
11 May 2020 CS01 Confirmation statement made on 9 May 2020 with no updates
01 May 2020 AP01 Appointment of Dr Michelle Grenan as a director on 1 May 2020
03 Dec 2019 AA Full accounts made up to 30 April 2019
05 Aug 2019 AP01 Appointment of Mr Ian Pritchard as a director on 5 August 2019
21 Jun 2019 PSC02 Notification of Cst Holdings (Uk) Limited as a person with significant control on 9 May 2017
21 Jun 2019 PSC09 Withdrawal of a person with significant control statement on 21 June 2019
21 May 2019 TM01 Termination of appointment of Daniel Mark O'connor as a director on 21 May 2019
16 May 2019 CS01 Confirmation statement made on 9 May 2019 with no updates